Treatment prevalence and incidence of schizophrenia in Quebec using a population health services perspective: different algorithms, different estimates
- PMID: 21445625
- DOI: 10.1007/s00127-011-0371-y
Treatment prevalence and incidence of schizophrenia in Quebec using a population health services perspective: different algorithms, different estimates
Abstract
Purpose: Using a population health services perspective, this article defines and assesses an efficient criteria-based algorithm to identify treatment prevalent and incident cases of schizophrenia. We refer here "treatment" prevalence and incidence since its evaluation depends on a patient receiving a health care service with a diagnosis of schizophrenia.
Methods: A population-based cohort study was conducted among all adults having a hospital discharge or a physician claim for schizophrenia in the public health plan databases between January 1996 and December 2006. Four algorithms to characterize patients with schizophrenia were defined. To identify treatment incident cases in 2006, we removed from the treatment prevalent pool patients with a previous record of schizophrenia between 1996 and 2006 (10-year clearance period). Using this 10-year period as reference, Kappa coefficients (KC) and positive predictive values (PPV) were calculated to determine the "optimal" length of clearance period to identify incident cases.
Results: The lifetime treatment prevalence and incidence of schizophrenia varied from 0.59 to 1.46% and from 42 to 94 per 100,000, respectively. When compared to the 10-year clearance period, the KC is excellent in a clearance period of 6-7 years. To achieve a PPV of 90%, a clearance period of 7-8 years would be necessary.
Conclusions: With an appropriate algorithm, treatment prevalence and incidence of schizophrenia can be conveniently estimated using administrative data. These estimates are a vital step toward appropriate planning of services for schizophrenia.
Similar articles
-
Performance of claims-based algorithms for identifying incident thyroid cancer in commercial health plan enrollees receiving antidiabetic drug therapies.BMC Health Serv Res. 2017 May 5;17(1):330. doi: 10.1186/s12913-017-2259-3. BMC Health Serv Res. 2017. PMID: 28476125 Free PMC article.
-
Rheumatoid arthritis prevalence in Quebec.BMC Res Notes. 2014 Dec 19;7:937. doi: 10.1186/1756-0500-7-937. BMC Res Notes. 2014. PMID: 25527187 Free PMC article.
-
The incidence of first-episode schizophrenia-spectrum psychosis in adolescents and young adults in montreal: an estimate from an administrative claims database.Can J Psychiatry. 2012 Oct;57(10):626-33. doi: 10.1177/070674371205701007. Can J Psychiatry. 2012. PMID: 23072954
-
A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data.Vaccine. 2013 Dec 30;31 Suppl 10:K41-61. doi: 10.1016/j.vaccine.2013.03.075. Vaccine. 2013. PMID: 24331074 Review.
-
Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Dec. Report No.: 13-05194-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Dec. Report No.: 13-05194-EF-1. PMID: 25632496 Free Books & Documents. Review.
Cited by
-
Optimal Look-Back Period to Identify True Incident Cases of Diabetes in Medical Insurance Data in the Chinese Population: Retrospective Analysis Study.JMIR Public Health Surveill. 2023 Nov 6;9:e46708. doi: 10.2196/46708. JMIR Public Health Surveill. 2023. PMID: 37930785 Free PMC article.
-
Sex differences in schizophrenia-spectrum diagnoses: results from a 30-year health record registry.Arch Womens Ment Health. 2024 Feb;27(1):11-20. doi: 10.1007/s00737-023-01371-8. Epub 2023 Sep 20. Arch Womens Ment Health. 2024. PMID: 37730924 Free PMC article.
-
Multidimensional analysis of adult patients' care trajectories before a first diagnosis of schizophrenia.Schizophrenia (Heidelb). 2022 May 19;8(1):52. doi: 10.1038/s41537-022-00256-6. Schizophrenia (Heidelb). 2022. PMID: 35854023 Free PMC article.
-
Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study.BMC Psychiatry. 2022 Jul 2;22(1):444. doi: 10.1186/s12888-022-04075-y. BMC Psychiatry. 2022. PMID: 35780116 Free PMC article.
-
10-Year Trends in Healthcare Spending among Patients with Schizophrenia in Alberta, Canada.Can J Psychiatry. 2022 Sep;67(9):723-733. doi: 10.1177/07067437221082885. Epub 2022 Mar 4. Can J Psychiatry. 2022. PMID: 35244485 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical